Emerging work now shows that these domains may be key to a central syndecan function, namely, acting as a “signaling organizer” at the cell surface by providing docking sites for other plasma membrane receptors, especially integrins and RTKs with well-known roles in cancer, that are highly dependent on the syndecan for their activation and signaling. Here, SDC1 is linked to cancer.